Ketamine

Half-Life (t½)
IV: 2.5h · IN: 2.5h
Formula
C13H16ClNO
Molecular Weight
237.73 g/mol
PubChem CID
3821
Aliases
Ketalar

Pharmacological Mechanism

Non-competitive NMDA receptor antagonist (open-channel blocker) + opioid + monoamine reuptake effects. Dissociative anesthetic preserving airway reflexes. Sub-anesthetic IV / intranasal (esketamine) for treatment-resistant depression. Schedule III; recreational misuse signal.

Half-Life & Elimination Curve (IV: 2.5h · IN: 2.5h)

100%50%25%12.5%0%0h0×t½2.5h1×t½5h2×t½7.5h3×t½10h4×t½12.5h5×t½0×t½ (0h): 100% remaining (~5 µg/L)1×t½ (2.5h): 50% remaining (~2.5 µg/L)2×t½ (5h): 25% remaining (~1.25 µg/L)3×t½ (7.5h): 12.5% remaining (~0.625 µg/L)4×t½ (10h): 6.3% remaining (~0.313 µg/L)5×t½ (12.5h): 3.1% remaining (~0.156 µg/L)
Elimination (IV)Effect Site (ke0)
  • 0×t½0h100% (5 µg/L)
  • 1×t½2.5h50% (2.5 µg/L)
  • 2×t½5h25% (1.25 µg/L)
  • 3×t½7.5h12.5% (0.625 µg/L)
  • 4×t½10h6.3% (0.313 µg/L)
  • 5×t½12.5h3.1% (0.156 µg/L)
Elimination t½2.5h (IV)
Rate Constant (ke)0.277 h⁻¹
Est. Peak (Cmax)5 µg/L
Clearance (CL)55.5 L/h
97% Washout (5×t½)12.5h

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References